Plunkett Research Online: Burzynski Research Institute Inc

BURZYNSKI RESEARCH INSTITUTE INC (BZYR:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Burzynski Research Institute Inc engages in the research, production, marketing, promotion and sale of certain medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives and organic acids which are known under the trade name Antineoplastons. The Antineoplastons are use.....



Burzynski Research Institute Inc
Ticker: BZYR
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 713 335-5697
Fax: 713 335-5699
Address: 9432 Katy Freeway
Houston, TX 77055 United States

Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
ContactsDescription
Stanislaw BurzynskiChairman of the Board/Director/President
Barbara BurzynskiDirector
See More
Burzynski Research Institute Inc engages in the research, production, marketing, promotion and sale of certain medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives and organic acids which are known under the trade name Antineoplastons. The Antineoplastons are use.....See More See More

Auditor: Pannell Kerr Forster of Texas, P.C.
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: